Cepheid (CPHD +16%) jumps after reporting a solid Q2. Revenue easily topped estimates on strong...

|By:, SA News Editor

Cepheid (CPHD +16%) jumps after reporting a solid Q2. Revenue easily topped estimates on strong growth in its clinical segment and international sales. Baird analyst Quintin Lai comments in a note the company's results "continue to impress."